The expression of miR-18b is significantly reduced in patient-derived melanomas and cell lines due to the hypermethylation of the p53 pathway, while its stable overexpression results in potent tumour suppressor activity as measured by cell viability, the induction of apoptosis, and reduction in tumour growth in xenograft assays [31]. Here, TP53 is linked to melanoma.